Elexacaftor/tezacaftor/ivacaftor as an essential medicine: an opportunity for action
File(s) Manuscript.docx (59.79 KB) Figure 1.pdf (82.42 KB)
Accepted version
Supporting information
Author(s)
Type
Journal Article
Date Issued
2025-12-01
Date Acceptance
2025-10-06
Citation
The Lancet Respiratory Medicine, 2025, 13 (12), pp.1048-1050
ISSN
2213-2600
Publisher
Elsevier
Start Page
1048
End Page
1050
Journal / Book Title
The Lancet Respiratory Medicine
Volume
13
Issue
12
Copyright Statement
Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/
Publication Status
Published
Date Publish Online
2025-10-22
